首页> 外国专利> Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for the prevention of cancer in at- risk subjects

Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for the prevention of cancer in at- risk subjects

机译:用于鉴定有癌症风险的受试者和预防高风险受试者的癌症的方法,药物制剂和试剂盒

摘要

Subjects at risk for developing cancer may be identified by obtaining samples of diagnostic cells from the subjects and determining a measure of cytotoxicity of the cells, the measure of cytotoxicity correlating negatively with the risk of developing cancer. The development of cancer may be prevented in subjects determined to be at risk for developing cancer by administering priming and activating agents to the subject, by increasing the expression of A1 adenosine receptors in cells of the subject, and increasing the affinity of cells of the subject for A1 adenosine receptor ligands. The preventative and diagnostic methods of the present invention may be carried out with kits and pharmaceutical liposomal formulations.
机译:可以通过从受试者获得诊断细胞的样品并确定细胞的细胞毒性的量度来鉴定处于患癌症风险的受试者,该细胞毒性的量度与患癌症的风险负相关。通过确定引发和活化剂,增加A 1 腺苷受体在受试者细胞中的表达,可以预防被确定有患癌症危险的受试者发生癌症,以及增加受试者细胞对A 1 腺苷受体配体的亲和力。本发明的预防和诊断方法可以用试剂盒和药物脂质体制剂进行。

著录项

  • 公开/公告号US2002160415A1

    专利类型

  • 公开/公告日2002-10-31

    原文格式PDF

  • 申请/专利权人 NEELY CONSTANCE F.;

    申请/专利号US20000569394

  • 发明设计人 CONSTANCE F. NEELY;

    申请日2000-05-12

  • 分类号A01N1/00;A01N1/02;C12Q1/00;G01N33/53;G01N33/574;G01N33/555;G01N33/567;A61K49/00;C12N5/00;C12N5/02;C07K1/00;C07K14/00;C07K17/00;

  • 国家 US

  • 入库时间 2022-08-22 00:51:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号